21-46116028-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001849.4(COL6A2):c.875G>T(p.Gly292Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G292S) has been classified as Pathogenic.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Publications
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1BInheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
- Bethlem myopathy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myosclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.875G>T | p.Gly292Val | missense_variant | Exon 7 of 28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.875G>T | p.Gly292Val | missense_variant | Exon 7 of 28 | NP_478054.2 | ||
COL6A2 | NM_058175.3 | c.875G>T | p.Gly292Val | missense_variant | Exon 7 of 28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.875G>T | p.Gly292Val | missense_variant | Exon 7 of 28 | 1 | NM_001849.4 | ENSP00000300527.4 | ||
COL6A2 | ENST00000397763.6 | c.875G>T | p.Gly292Val | missense_variant | Exon 7 of 28 | 5 | ENSP00000380870.1 | |||
COL6A2 | ENST00000409416.6 | c.875G>T | p.Gly292Val | missense_variant | Exon 6 of 27 | 5 | ENSP00000387115.1 | |||
COL6A2 | ENST00000485591.1 | n.531G>T | non_coding_transcript_exon_variant | Exon 3 of 7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1450496Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 720858
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
PS2, PS4_Moderate, PM6_strong, PM1 -
Bethlem myopathy 1A Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with valine at codon 292 of the COL6A2 protein (p.Gly292Val). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and valine. This variant has been observed to be de novo in several individuals affected with congenital muscular dystrophy (PMID: 17785673, 24038877). Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL6A2, missense variants at these glycine residues are significantly enriched in individuals with disease (PMID: 15689448, 24038877) compared to the general population (ExAC). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at